Dietary supplementation with seed oil from transgenic Camelina sativa induces similar increments in plasma and erythrocyte DHA and EPA to fish oil in healthy humans. Issue 9 (14th November 2020)

• Record Type: Journal Article
• Authors: West, Annette L.; Miles, Elizabeth A.; Lillycrop, Karen A.; Han, Lihua; Napier, Johnathan A.; Calder, Philip C.; Burdge, Graham C.
• Is Part Of: British journal of nutrition. Volume 124:Issue 9(2020)
• Page Start: 922
• Page End: 930
• Publication Date: 2020-11-14
• Subjects: Transgenic plants, -- Camelina sativa, -- DHA, -- EPA, -- Dietary supplementation; Nutrition -- Periodicals; 572.4
• DOI: 10.1017/S0007114520002044
• Languages: English
• ISSNs: 0007-1145

Abstract

Abstract: EPA and DHA are required for normal cell function and can also induce health benefits. Oily fish are the main source of EPA and DHA for human consumption. However, food choices and concerns about the sustainability of marine fish stocks limit the effectiveness of dietary recommendations for EPA + DHA intakes. Seed oils from transgenic plants that contain EPA + DHA are a potential alternative source of EPA and DHA. The present study investigated whether dietary supplementation with transgenic Camelina sativa seed oil (CSO) that contained EPA and DHA was as effective as fish oil (FO) in increasing EPA and DHA concentrations when consumed as a dietary supplement in a blinded crossover study. Healthy men and women ( n 31; age 53 (range 20–74) years) were randomised to consume 450 mg/d EPA + DHA provided either as either CSO or FO for 8 weeks, followed by 6 weeks washout and then switched to consuming the other test oil. Fasting venous blood samples were collected at the start and end of each supplementation period. Consuming the test oils significantly ( P < 0·05) increased EPA and DHA concentrations in plasma TAG, phosphatidylcholine and cholesteryl esters. There were no significant differences between test oils in the increments of EPA and DHA. There was no significant difference between test oils in the increase in the proportion of erythrocyte EPA + DHA (CSO, 12 %; P < 0·0001 and FO, 8 %; P = 0·02). Together, these findings show that consuming CSO is as effective as FO for increasing EPA and DHA concentrations in humans.